CHINOOK TRANSPORTATION SERVICES
CHINOOK TRANSPORTATION SERVICES
Industry:
Food Delivery Logistics Transportation
Address:
Yakima, Washington, United States
Country:
United States
Website Url:
http://www.chinookts.com
Status:
Active
Contact:
1-888-222-1019
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS
Official Site Inspections
http://www.chinookts.com
- Host name: ngcluster.msg.chrl.nc.charter.net
- IP address: 47.43.22.53
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Chinook Transportation Services"
Novartis completes acquisition of Chinook Therapeutics
Acquisition of Chinook Therapeutics, a clinical-stage biopharmaceutical company, completed for USD 3.2bn upfront; Deal brings two phase 3 assets in development for IgAN; atrasentan, an โฆSee details»
Chinook Therapeutics - LinkedIn
Chinook Therapeutics is now a Novartis Company! On August 11, 2023, Novartis completed its acquisition of Chinook. Follow Novartis to stay updated on atrasentan, zigakibart (BION-1301) โฆSee details»
Novartis bolsters innovative medicines strategy and renal pipeline โฆ
Jun 12, 2023 These documents (when available) may be obtained free of charge from the SECโs website at www.sec.gov, Novartis website at https://www.novartis.com and Chinookโs website โฆSee details»
Novartis
Mar 28, 2025 Patient organization funding Payments to healthcare professionals Public policy A living wage A safe workplace Animal research Environmental, social and governance. Learn โฆSee details»
Chinook Therapeutics - Crunchbase Company Profile & Funding
Www.chinooktx.com ; 16,106; Highlights. Acquisitions 1. obfuscated. Total Funding Amount . Unlock for free . Contacts 119. Employee Profiles 7. ... Furthermore, being part of a larger โฆSee details»
Chinook Therapeutics Enters Into Agreement to be Acquired by โฆ
Jun 12, 2023 The transaction is expected to be completed in the second half of 2023, subject to customary closing conditions.See details»
Chinook Therapeutics, Inc. - AnnualReports.com
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases. Chinookโs product candidates are being investigated in rare, โฆSee details»
Chinook Therapeutics, a Novartis Company Overview
Chinook Therapeutics is now a Novartis Company! On August 11, 2023, Novartis completed its acquisition of Chinook. Follow the Novartis channel or visit www.novartis.com to stay updated โฆSee details»
Chinook Therapeutics
Feb 25, 2025 Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases.See details»
Chinook Therapeutics Enters into Agreement to be Acquired
Jun 12, 2023 Novartis to acquire Chinook for $40 per share in cash, with potential to receive up to an additional $4 per share in cash through contingent value rights, for a total equity value of โฆSee details»
Chinook Therapeutics - Craft
Chinook Therapeutics is a biotechnology company developing precision medicines for kidney diseases. It offers atrasentan, a potent and selective endothelin A (ETA) receptor antagonist; โฆSee details»
Chinook Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Ww.chinooktx.com. Public Company | Subsidiary Company | 2019 | Canada | 100-250 | NASDAQ: KDNY | ww.chinooktx.com. Last update 08 Mar 2025. Overview. Pipeline. Deal. Translational โฆSee details»
Chinook Therapeutics - PitchBook
Chinook Therapeutics General Information Description. Chinook Therapeutics Inc is a clinical-stage biotechnology company. The products of the company are focused on rare, severe โฆSee details»
CHINOOK THERAPEUTICS CLOSES MERGER WITH ADURO โฆ
Combined CompanyWillHave Over $275 Million in Operating Capital andTrade on Nasdaq under the Ticker Symbol โKDNYโ VANCOUVER, British Columbia and SEATTLE, Oct. 05, 2020 โฆSee details»
Chinook Therapeutics Enters Into Agreement to be Acquired by โฆ
Jun 12, 2023 Corporate Office. 623 Fifth Avenue 14th Floor New York, NY 10022. P: (212) 887-2100 E: [email protected]See details»
Chinook Therapeutics (KDNY) | Portfolio | Versant Ventures
Chinook is developing precision medicines for kidney diseases. The company is applying its proprietary discovery platform, which leverages single cell RNA sequencing, human-derived โฆSee details»
Chinook Therapeutics Announces the Appointment of Robert W.
SEATTLE, April 13, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of โฆSee details»
Chinook Therapeutics, A Novartis Company - Company Profile
Discover Chinook Therapeutics, A Novartis Company's contact details, including key employeesโ emails and phone numbers. Explore company insights and data through Leadmap's company โฆSee details»
Chinook Therapeutics Announces the Appointment of Robert W
SEATTLE, April 13, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc., (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization โฆSee details»
Chinook Therapeutics Inc: Locations - GlobalData
View Chinook Therapeutics Inc's company headquarters address along with its other key offices and locations.See details»